NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . September 8th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Massachusetts General Hospital - Potential diabetes treatment selectively kills autoimmune cells from human patients

Drug Resistance - PolyMedix Initiates Dosing in Phase I Clinical Study of Novel Systemic Antibiotic Compound

The Medicines Company - New Publication Shows Cleviprex is Safe and Effective for Treatment of Acute, Severe Hypertension

Angiogenesis - Research from New York University, Medical Department in angiogenesis provides new insights

Chronic Myelogenous Leukemia - New chronic myelogenous leukemia findings from University of Heidelberg published

Clinical Trial Research - New clinical trial research findings from Duke University published

HIV/AIDS - Studies by B. Autran and co-authors describe new findings in HIV/AIDS

Kidney Transplants - Scientists at University of Schleswig-Holstein target kidney transplants

Lymphoma - Data from T. Robak and colleagues advance knowledge in lymphoma

Melanoma - Researchers at National Institutes of Health target melanoma

Melanoma - Scientists at University of Kiel publish new data on melanoma

Prostate Cancer - Researchers from University of British Columbia report on findings in prostate cancer

Alzheimer Disease - Uppsala University publishes research in Alzheimer disease

Cancer Therapy - Researchers from Kinki University, Department of Medical Oncology detail findings in cancer therapy

Clinical Trial Research - New clinical trial research study results reported from Royal Marsden Hospital

Gas Chromatography - Study data from Amgen, Inc. provide new insights into gas chromatography

Glioma Therapy - Research on glioma therapy described by scientists at Cedars-Sinai Medical Center

Hepatocellular Cancer - Research from National Cancer Center, Department of Medical Oncology provides new data about hepatocellular cancer in children

Melanoma Therapy - Research from C. Ménard and co-authors reveals new findings on melanoma therapy

Multiple Sclerosis Clinical Trial - New findings in multiple sclerosis clinical trial described from Vrije University, Department of Radiology

Multiple Sclerosis Therapy - Studies from University of Michigan, Department of Neurology add new findings in the area of multiple sclerosis therapy

Pharmacodynamics - Studies from Peking Union Medical College provide new data on pharmacodynamics

Pharmacokinetics - Research from Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center in the area of pharmacokinetics published

Phototherapy - Data from University of Manchester, Paterson Institute for Cancer Research advance knowledge in phototherapy

Rotavirus Vaccines - Research reports on rotavirus vaccines from National University provide new insights

Smoking - Research findings from K.M. Becker et al update understanding of smoking

Substance Withdrawal Syndrome Therapy - Data on substance withdrawal syndrome therapy discussed by researchers at University of Pennsylvania

Angiogenesis - SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines

Arthroscopy - Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: the Journal of Arthroscopic and Related Surgery

AVEO Pharmaceuticals, Inc. - AVEO Initiates Phase 1b Combination Trial of AV-951 with FOLFOX6 in Patients with Advanced Colorectal and Other Gastrointestinal Cancers

Biotech Business - MDS Pharma Services Strengthens Medical Leadership in Phase IIa Clinical Research

Bird Flu - Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program

Cell Genesys, Inc. - Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer

Celsion Corporation - ThermoDox Liver Cancer Study Phase I Results to Be Presented at ILCA Conference 2008

Clinical Research - After Their U.S. Purchase, Algorithme Pharma Gains a Foothold in Europe Through the Acquisition of a New Clinical Research Location in the United Kingdom

Clinical Trial Research - Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial

Clinical Trial Research - Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen Therapy(TM) of the Full Face Regarding the Treatment of Wrinkles and Skin Quality Characteristics

Curis, Inc. - Curis Announces Nature Publication Elucidating a Paracrine Mechanism of Action in Hedgehog-Expressing Tumors

Diabetic Retinopathy - NicOx Provides Update on PF-03187207 and the Ongoing Research Collaboration With Pfizer

Flu Vaccines - VaxInnates M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study

Memory Pharmaceuticals Corp. - Memory Pharmaceuticals Closes Final Tranche of Equity Financing with the Stanley Medical Research Institute

Morphotek, Inc. - Morphotek, Inc. Expands Its Phase II Trial Site Selections in the European Union

Neurodegenerative Disease - Eric Karran, CSO of the Neurodegenerative Diseases Drug Hunting Team at Eli Lilly & Co. to Give Keynote Presentation at GTCbios 4th Neurodegenerative Diseases Drug Discovery Conference in Philadelphia, PA

Oxygen Biotherapeutics, Inc. - Oxygen Biotherapeutics, Inc. to Meet With FDA to Discuss Proposed Phase II-b Oxycyte Clinical Trial

Pfizer Inc - Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program

Pharmos Corporation - Pharmos Corporation Announces That it Will Cease Operations in Israel

Pneumonia - Sharath Hegde, Vice President at Theravance to Give Featured Presentation at GTCbios Bugs & Drugs Conference in San Diego, CA

The Multiple Myeloma Research Consortium - The Multiple Myeloma Research Consortium MMRC Partners with Celgene Corporation on Phase I/II Trial of Pomalidomide CC-4047 in Relapsed and Refractory Multiple Myeloma Patients

Vaccines - Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection



Return to Top of Page

-----------------------
PR Login